Company Filing History:
2 out of 70 
1 out of 1,289 
Years Active: 2016-2021
Title: Shashi Kumar Gupta: Innovator in Cardiac Research
Introduction
Shashi Kumar Gupta is a prominent inventor based in Hannover, Germany. He has made significant contributions to the field of cardiac research, particularly through his innovative patents. With a total of 2 patents, Gupta's work focuses on therapeutic targets for cardiac disorders.
Latest Patents
Gupta's latest patents include "LNCRNA MEG3 for therapy and diagnosis of cardiac remodelling." This invention relates to a compound that inhibits the expression and/or activity of maternally expressed 3 (Meg3) for use in treating or preventing cardiac remodelling. Another notable patent is "miRNA-212/132 family as a therapeutic target." This invention refers to inhibitors of microRNAs, specifically miR-212 and/or miR-132, for use in medicine, particularly in the diagnosis, treatment, or prevention of cardiac disorders such as cardiac hypertrophy-associated or autophagic disorders.
Career Highlights
Throughout his career, Gupta has worked with esteemed institutions, including the Medical University of Hannover and the Max Planck Society for the Advancement of Science. His research has significantly advanced the understanding of cardiac conditions and potential treatments.
Collaborations
Gupta has collaborated with notable colleagues, including Thomas Thum and Maria-Teresa Piccoli, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Shashi Kumar Gupta's innovative work in cardiac research exemplifies the importance of targeted therapies in medicine. His contributions continue to pave the way for advancements in the treatment of cardiac disorders.